Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBPET.L Regulatory News (BPET)

  • There is currently no data for BPET

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Third Quarter Results and Dividend Announcement

22 Nov 2019 07:00

RNS Number : 2767U
BMO Private Equity Trust PLC
22 November 2019
 

 

To: Stock Exchange

For immediate release:

 

22 November 2019

 

BMO Private Equity Trust PLC

Quarterly results for the three months to 30 September 2019 (unaudited) 

·; Share price total return for the three months of 3.4 per cent for the Ordinary Shares

·; Net asset value of 390.81p per Ordinary Share reflecting a total return for the three months of 1.7 per cent for the Ordinary Shares

·; Quarterly dividend of 3.87p per Ordinary Share to be paid on 31 January 2020

 

 

 

Introduction

As at 30 September 2019, the net assets of the Company were £289.0 million giving a net asset value ("NAV") per share of 390.81p and a total return over the quarter of 1.7%. For the first nine months of the year, the NAV total return was 4.1%. With the discount reducing from 17.9% at 31 December 2018 to 7.6% at 30 September 2019 the share price total return for this nine-month period was an impressive 17.6%.  At 30 September 2019 the Company had net debt of £27.5 million. Outstanding undrawn commitments were £124.1 million with approximately £17.5 million of these to funds where the investment period has expired and where we would expect only a small proportion to be drawn.

 

The next quarterly dividend of 3.87p per share will be paid on 31 January 2020 to shareholders on the register on 10 January 2020. The ex-dividend date is 9 January 2020.

 

New Investments

There were no new investments in the third quarter. A substantial 'follow-on' investment of £3.0 million was made into oil services company Ashtead Technology. This was to enable our investor group, led by energy specialists Buckthorn, to buy-out a large minority shareholder. Ashtead has made good progress recently as demand for its subsea monitoring equipment has picked up.

 

After the quarter end we completed a co-investment of £4.1 million into Amethyst Radiotherapy. This is a chain of radiotherapy clinics located across Europe from Poland to France. The investment is led by The Rohatyn Group, who specialise in Central and Eastern Europe. The investment case centres on a significant expansion of the number of clinics across Europe. Advances in medical science mean that radiotherapy clinics with the latest equipment are in strong demand. Also, in our co-investment portfolio £0.3 million was added to RGI, the Italy based provider of software for the insurance sector, which has made an acquisition of a complementary business operating in German speaking Europe.

 

The funds in our portfolio have been active in building out their portfolios. The larger drawdowns are quite diverse by geography and industrial sector. In the UK August Equity Partners IV called £0.6 million for Esland (residential care for young people with special needs). Piper Private Equity VI called £0.3 million for Mous Products (tech accessories). In Germany Bencis V called £0.4 million for Gebhardt-Stahl (steel reinforcement profiles for the HVAC systems and PVCu window frames). DBAG VII called £0.5 million for Kraft&Bauer (fire extinguishing systems for tooling machinery). In the Nordic region the funds have also been active. Procuritas Capital VI called £0.4 million for Temporary Space (temporary accommodation for schools, health centres and offices). Summa I called £0.3 million for LOGEX Group (data analytics software to improve healthcare outcomes). Vaaka Partners Buyout Fund III called £0.3 million for Lyyti (Finnish market leader for event management software). In the USA Stellex called £0.3 million for the combined investment in ship repair companies MHI and Vigor. MHI was an existing Stellex investment that has been merged with and sold into Vigor. The Carlyle Group has backed the deal and assumed the leadership position.

 

Total drawdowns and co-investments in the third quarter were £11.2 million bringing the total for the year to date to £39.2 million. This is approximately 25% below the cumulative investments by this stage last year.

 

 

 

 

 

Realisations

 

Realisations and income received for the quarter was £6.4 million giving a total for the year of £31.8 million.

 

It has been a fairly quiet quarter with no large exits from the co-investment portfolio. There were several smaller realisations from across the fund's portfolio. In the UK Horizon Capital (formerly Lyceum) made a partial exit of media company AgriBriefing through a refinancing returning £0.7 million, 1.5x cost. Inflexion 2010 Fund sold agricultural laboratory testing services business Cawood Scientific to Waterland Private Equity returning £0.4 million or 2.8x cost and 43% IRR. Venture capital fund SEP IV sold cloud storage and document collaboration business Workshare to trade buyer Litera Microsystems returning £0.2 million, 2.0x cost, 11% IRR.

 

In France, as previously reported, Chequers Capital XV exited thermal solutions and temperature measurement systems for cables company Thermocoax returning £0.7 million, 2.7x cost. In Germany DBAG VI sold specialised films for consumer goods packaging business Infiana to financial buyer Pamplona returning £0.4 million, 2.1x cost, 25% IRR. Lastly and, most significantly, in the USA Blue Point Capital III sold The Hilsinger Company, a global supplier of optical accessories and products, returning £1.1 million, 3.7x cost, 28% IRR.

 

Valuation Changes

 

There were a number of valuation changes in both directions this quarter. The largest positive (£1.4 million) was from our co-investment in Croatia based large format pet retailer Pet Network (TRG Pluto) which has traded strongly. There was another uplift of £1.3 million from the receipt, after the quarter end, of a deferred consideration relating to our previous holding in fishing tackle company Fox. This was sold by Nextwave to Mayfair Partners in 2015 with the deal including the potential for the vendors to benefit from a subsequent sale. Mayfair have now sold Fox to a strategic buyer in the US and that has triggered a deferred payment of £1.3 million. As we were carrying this entitlement at nil value it is an effective uplift of the full amount. Elsewhere in the portfolio there has been good progress with an uplift of £0.8 million from TDR II mainly driven by the movement in the share price of Williams Scotsman, the modular buildings company. Volpi Capital I is up by £0.7 million reflecting good progress in its portfolio. In Spain Corpfin Capital IV is up by £0.7 million reflecting actual and imminent realisations within a strongly performing portfolio. Astorg VI also has a performing portfolio and is uplifted by £0.6 million. August Equity Partners IV is doing well and a broadly-based uplift totalled £0.5 million.

 

There were a few setbacks in valuations. Avalon, the funeral plans provider, faces a difficult market which is down, at least in part, in response to some regulatory changes which will see the FCA start regulating the sale of funeral plans. In the longer term this should benefit Avalon but in the short term it has necessitated a downgrade of £2.1 million. Our holding in clothing company Weird Fish has been struggling against a very soft market and this is downgraded by £1.4 million. Our US based restaurant chain Rosa Mexicano has experienced poor trading and has been written down by £1.0 million. Following the quarter end Rosa Mexicano has been refinanced.

 

Financing

The Company has a large amount of headroom on its borrowing facility with the term loan of €25 million (£20.9 million) fully drawn and £9.7 million of the £75 million revolving credit facility drawn giving £66 million available subject to covenant compliance. With net debt of £27.5 million, or just under 10% of NAV, this is a useful amount of gearing which should enhance shareholder returns. It looks likely that the total proceeds from realisations for 2019 will be some way below the record total for 2018. This quarter is unusual of late in that there was no net effect from currency movements.

 

 

 

Outlook

Activity within the private equity market internationally remains at healthy levels albeit below 2018 levels. This is backed by on going appetite for the asset class and strong fund raising. New deals are being initiated in all markets in near record volumes. The very strong market for exits which has characterised the last three years is showing some signs of catching its breath. The trading performance of the portfolio is robust with a limited number of sector or company specific areas of concern. The price of new deals remains high by historic standards driven in part by the considerable amounts of private equity commitments and abundant cheap debt. Despite this the lower mid market in Europe remains relatively less expensive and continues to be a good hunting ground for our value-oriented investment partners. The heterogenous nature of our dealflow also continues. At this stage in the year, there is considerable scope to build further shareholder value.

 

 

 

Hamish Mair

Investment Manager

BMO Investment Business Limited

 

 

 

 

 

 

 

 

 

 

 

BMO PRIVATE EQUITY TRUST PLC

 

Statement of Comprehensive Income for the

nine months ended 30 September 2019 (unaudited)

 

 

 

 

 

Revenue

£'000

Capital

£'000

Total

£'000

 

Income

 

 

 

Gains on investments held at fair value

-

13,081

13,081

Exchange gains

-

588

588

Investment income

3,010

-

3,010

Other income

56

-

56

Total income

3,066

13,669

16,735

 

 

 

 

Expenditure

 

 

 

Investment management fee - basic fee

(206)

(1,858)

(2,064)

Investment management fee - performance fee

-

(1,289)

(1,289)

Other expenses

(619)

-

(619)

Total expenditure

(825)

(3,147)

(3,972)

 

 

 

 

Profit before finance costs and taxation

2,241

10,522

12,763

 

 

 

 

Finance costs

(132)

(1,190)

(1,322)

 

 

 

 

Profit before taxation

2,109

9,332

11,441

 

 

 

 

Taxation

(401)

401

-

 

 

 

 

Profit for period/total comprehensive income

1,708

9,733

11,441

 

 

 

 

Return per Ordinary Share

2.31p

13.16p

15.47p

 

 

 

 

 

 

 

 

 

 

 

BMO PRIVATE EQUITY TRUST PLC

 

Statement of Comprehensive Income for the

nine months ended 30 September 2018 (unaudited)

 

 

 

 

 

Revenue

£'000

Capital

£'000

Total

£'000

 

Income

 

 

 

Gains on investments held at fair value

-

20,913

20,913

Exchange gains

-

216

216

Investment income

944

-

944

Other income

49

-

49

Total income

993

21,129

22,122

 

 

 

 

Expenditure

 

 

 

Investment management fee - basic fee

(486)

(1,457)

(1,943)

Investment management fee - performance fee

-

(2,123)

(2,123)

Other expenses

(582)

-

(582)

Total expenditure

(1,068)

(3,580)

(4,648)

 

 

 

 

(Loss)/profit before finance costs and taxation

(75)

17,549

17,474

 

 

 

 

Finance costs

(320)

(958)

(1,278)

 

 

 

 

(Loss)/profit before taxation

(395)

16,591

16,196

 

 

 

 

Taxation

-

-

-

 

 

 

 

(Loss)/profit for period/total comprehensive income

(395)

16,591

16,196

 

 

 

 

Return per Ordinary Share

(0.53)p

22.44p

21.91p

 

 

 

 

 

 

 

 

BMO PRIVATE EQUITY TRUST PLC

 

Statement of Comprehensive Income for the

year ended 31 December 2018 (audited)

 

 

 

 

 

Revenue

£'000

Capital

£'000

Total

£'000

 

Income

 

 

 

Gains on investments held at fair value

-

36,966

36,966

Exchange gains

-

35

35

Investment income

2,340

-

2,340

Other income

81

-

81

Total income

2,421

37,001

39,422

 

 

 

 

Expenditure

 

 

 

Investment management fee - basic fee

(660)

(1,980)

(2,640)

Investment management fee - performance fee

-

(2,277)

(2,277)

Other expenses

(760)

-

(760)

Total expenditure

(1,420)

(4,257)

(5,677)

 

 

 

 

Profit before finance costs and taxation

1,001

32,744

33,745

 

 

 

 

Finance costs

(428)

(1,286)

(1,714)

 

 

 

 

Profit before taxation

573

31,458

32,031

 

 

 

 

Taxation

(109)

109

-

 

 

 

 

Profit for year/total comprehensive income

464

31,567

32,031

 

 

 

 

Return per Ordinary Share

0.63p

42.69p

43.32p

 

 

 

 

 

 

 

BMO PRIVATE EQUITY TRUST PLC

 

Balance Sheet

 

 

 

 

As at 30 September 2019

As at 30 September 2018

As at 31 December

2018

 

(unaudited)

(unaudited)

(audited)

 

£'000

£'000

 £'000

Non-current assets

 

 

 

Investments at fair value through profit or loss

318,825

278,914

295,242

 

 

 

 

Current assets

 

 

 

Other receivables

21

23

142

Cash and cash equivalents

3,188

23,239

21,335

 

3,209

23,262

21,477

 

 

 

 

Current liabilities

 

 

 

Other payables

(2,389)

(3,179)

(4,267)

Interest-bearing bank loan

(9,732)

-

(26,821)

 

(12,121)

(3,179)

(31,088)

Net current (liabilities)/assets

(8,912)

20,083

(9,611)

Total assets less current liabilities

309,913

298,997

285,631

Non-current liabilities

 

 

 

Interest-bearing bank loan

(20,945)

(26,561)

-

Net assets

288,968

272,436

285,631

 

 

 

 

Equity

 

 

 

Called-up ordinary share capital

739

739

739

Share premium account

2,527

2,527

2,527

Special distributable capital reserve

15,040

15,040

15,040

Special distributable revenue reserve

31,403

31,403

31,403

Capital redemption reserve

1,335

1,335

1,335

Capital reserve

237,924

221,787

234,587

Revenue reserve

-

(395)

-

Shareholders' funds

288,968

272,436

285,631

 

 

 

 

Net asset value per Ordinary Share

390.81p

368.45p

386.29p

 

 

 

 

 

 

BMO PRIVATE EQUITY TRUST PLC

Reconciliation of Movements in Shareholders' Funds

 

 

 

 

 

Nine months ended

30 September

2019

Nine months ended

30 September 2018

Year

ended

31 December 2018

 

(unaudited)

(unaudited)

(audited)

 

£'000

£'000

£'000

Opening shareholders' funds

285,631

264,144

264,144

Profit for the period/total

comprehensive income

 

11,441

 

16,196

 

32,031

Dividends paid

(8,104)

(7,904)

(10,544)

 

Closing shareholders' funds

 

 

288,968

 

272,436

 

285,631

 

  Notes (unaudited)

 

1. The unaudited quarterly results have been prepared on the basis of the accounting policies set out in the statutory accounts of the Company for the year ended 31 December 2018. Earnings for the nine months to 30 September 2019 should not be taken as a guide to the results for the year to 31 December 2019.

 

During the year to 31 December 2018, the management fee and bank loan interest were allocated 75 per cent to capital and 25 per cent to revenue. In accordance with the Board's expected long term split of returns in the form of capital gains and income, with effect from 1 January 2019 the allocation basis has been revised to 90 per cent to capital and 10 per cent to revenue.

 

2. Investment management fee:

 

 

 

Nine months ended

30 September 2019

(unaudited)

 

 

Nine months ended

30 September 2018

(unaudited)

 

 

Year ended

31 December 2018

(audited)

 

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

 

 

 

 

 

 

 

 

 

 

Investment management fee - basic fee

 

206

 

1,858

 

2,064

 

486

 

1,457

 

1,943

 

660

 

1,980

 

2,640

Investment management fee - performance fee

 

-

 

1,289

 

1,289

 

-

 

2,123

 

2,123

 

-

 

2,277

 

2,277

 

 

206

 

3,147

 

3,353

 

486

 

3,580

 

4,066

 

660

 

4,257

 

4,917

 

 

 

 

 

 

 

 

 

 

 

3. Finance costs:

 

 

 

Nine months ended

30 September 2019

(unaudited)

 

 

Nine months ended

 30 September 2018

(unaudited)

 

 

Year ended

31 December 2018

(audited)

 

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

 

 

 

 

 

 

 

 

 

 

Interest payable on bank loans

132

1,190

1,322

320

958

1,278

428

1,286

1,714

 

 

 

 

 

 

 

 

 

 

 

4. Returns and net asset values

 

Nine months ended

30 September 2019

(unaudited)

Nine months ended

 30 September 2018

(unaudited)

Year ended

31 December 2018

(audited)

The returns and net asset values per share are based on the following figures:

 

 

 

 

Revenue Return

£1,708,000

(£395,000)

£464,000

Capital Return

£9,733,000

£16,591,000

£31,567,000

Net assets attributable to shareholders

£288,968,000

£272,436,000

£285,631,000

Number of shares in issue at end of period

73,941,429

73,941,429

73,941,429

Weighted average number of shares in issue during the year

73,941,429

73,941,429

73,941,429

 

 

 

 

 

5. The financial information for the nine months ended 30 September 2019, which has not been audited or reviewed by the Company's auditor, comprises non-statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2018, on which the auditor issued an unqualified report, have been lodged with the Registrar of Companies. The quarterly report is available on the Company's website www.bmoprivateequitytrust.com

 

Legal Entity Identifier: 2138009FW98WZFCGRN66

 

For more information, please contact:

 

Hamish Mair (Investment Manager)

0131 718 1184

Scott McEllen (Company Secretary)

0131 718 1137

hamish.mair@bmogam.com / scott.mcellen@bmogam.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
QRTPGGCWGUPBGQG
Date   Source Headline
30th Jun 20223:22 pmRNSChange of Name
17th Jun 20224:07 pmRNSTransaction in Own Shares
15th Jun 20225:01 pmRNSTransaction in Own Shares
27th May 20229:08 amRNSResult of Annual Gen Meeting & Directorate Change
26th May 202212:02 pmRNS1st Quarter Results
27th Apr 202210:07 amRNSDirector/PDMR Shareholding
27th Apr 202210:06 amRNSDirector/PDMR Shareholding
27th Apr 202210:04 amRNSDirector/PDMR Shareholding
26th Apr 20223:24 pmRNSDirector/PDMR Shareholding
26th Apr 20223:23 pmRNSDirector/PDMR Shareholding
25th Apr 20229:24 amRNSDirector/PDMR Shareholding
8th Apr 20227:00 amRNSAnnual Financial Report
1st Apr 202210:17 amRNSHolding(s) in Company
1st Apr 202210:09 amRNSHolding(s) in Company
30th Mar 20222:56 pmRNSDirector/PDMR Shareholding
30th Mar 20222:54 pmRNSDirector/PDMR Shareholding
25th Mar 20227:00 amRNSAnnual Financial Report
17th Feb 20227:00 amRNSDirectorate Change
14th Jan 20227:00 amRNSUpdate on Secondary Placing
13th Jan 20227:00 amRNSProposed Secondary Placing
4th Jan 20227:00 amRNSInvestor Presentation
26th Nov 20217:00 amRNS3rd Quarter Results
22nd Nov 202110:47 amRNSHolding(s) in Company
15th Oct 20219:55 amRNSHolding(s) in Company
15th Oct 20217:00 amRNSKepler Trust Intelligence: New Research
27th Aug 20217:00 amRNSInterim results and Quarterly Dividend
25th Jun 20213:14 pmRNSHolding(s) in Company
27th May 20212:15 pmRNSAGM Statement
27th May 202111:51 amRNSQuarterly NAV and Dividend Announcement
29th Apr 20211:01 pmRNSHolding(s) in Company
19th Apr 20217:00 amRNSAnnual Financial Report
26th Mar 20217:00 amRNSFinal Results
24th Mar 20217:00 amRNSInvestment Update
8th Feb 20213:00 pmRNSHolding(s) in Company
9th Dec 20209:22 amRNSHolding(s) in Company
27th Nov 202010:52 amRNSHolding(s) in Company
25th Nov 20209:18 amRNSKepler Trust Intelligence: New Research
20th Nov 20207:00 amRNSQuarterly results and dividend announcement
15th Oct 20204:09 pmRNSNon-Executive Director Declaration
18th Sep 20202:09 pmRNSDirector/PDMR Shareholding
16th Sep 20202:24 pmRNSDirector/PDMR Shareholding
15th Sep 20203:42 pmRNSHolding(s) in Company
1st Sep 202012:24 pmRNSDirector/PDMR Shareholding
21st Aug 20207:00 amRNSInterim Results
20th Jul 20207:00 amRNSNon-Executive Director Declaration
17th Jul 20207:00 amRNSAppointment of Corporate Broker
9th Jun 20209:57 amRNSHolding(s) in Company
4th Jun 20207:00 amRNSDirectorate Change
22nd May 20204:11 pmRNSHolding(s) in Company
21st May 20207:00 amRNSFirst Quarter Results and Dividend Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.